In a first, FDA approves fast-acting postpartum depression pill

Here’s what we know about the second drug to ever be approved for the post-pregnancy condition

Related Keywords

New York ,United States ,Tiffanyr Farchione ,Christopher Zahn ,Kristina Deligiannidis ,Feinstein Institutes For Medical Research In Manhasset ,Institute Of Behavioral Science ,Health Equity ,Drug Administration ,American College Of Obstetricians ,Division Of Psychiatry ,Crisis Lifeline ,Drug Evaluation ,Sage Therapeutics ,Behavioral Science ,Feinstein Institutes ,Medical Research ,American College ,Clinical Practice ,Postpartum Depression ,Food And Drug Administration ,